Anti-infective Vaccination Strategies in Patients with Hematologic Malignancies or Solid Tumors-Guideline of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO)

Overview

Journal Ann Oncol

Publisher Elsevier

Specialty Oncology

Date 2018 Apr 25

PMID 29688266

Citations 39

Authors

C T Rieger

B Liss

S Mellinghoff

D Buchheidt

O A Cornely

G Egerer

W J Heinz

M Hentrich

G Maschmeyer

K Mayer

M Sandherr

G Silling

A Ullmann

M J G T Vehreschild

M von Lilienfeld-Toal

H H Wolf

N Lehners

Affiliations

Soon will be listed here.

Abstract

Infectious complications are a significant cause of morbidity and mortality in patients with malignancies specifically when receiving anticancer treatments. Prevention of infection through vaccines is an important aspect of clinical care of cancer patients. Immunocompromising effects of the underlying disease as well as of antineoplastic therapies need to be considered when devising vaccination strategies. This guideline provides clinical recommendations on vaccine use in cancer patients including autologous stem cell transplant recipients, while allogeneic stem cell transplantation is subject of a separate guideline. The document was prepared by the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO) by reviewing currently available data and applying evidence-based medicine criteria.

Citing Articles

Humoral Response to SARS-CoV-2 Vaccine-Boost in Cancer Patients: A Case Series from a Southern European Cancer Center.

Oliveira J, Cruz P, Dias T, Sousa-Pimenta M, Almeida B, Soares B Vaccines (Basel). 2024; 12(11).

PMID: 39591110 PMC: 11598862. DOI: 10.3390/vaccines12111207.

The Clinical Significance of Viral Vulnerability and Iron Overload in T-cell Acute Lymphoblastic Leukemia.

Singh R, Pandey S, Mohit M, Habib N Asian Pac J Cancer Prev. 2024; 25(10):3339-3340.

PMID: 39470999 PMC: 11711359. DOI: 10.31557/APJCP.2024.25.10.3339.

Carrimycin in a Patient with Acute Myeloid Leukemia Complicated with Life-Threatening Mixed Perianal Infection: A Case Report and Literature Review.

Yang X, Shen Y, Hu T, Li H, Zhang Y, Shen Y Infect Drug Resist. 2024; 17:3637-3642.

PMID: 39184012 PMC: 11345016. DOI: 10.2147/IDR.S475982.

COVID-19 vaccine updates for people under different conditions.

Huang Y, Wang W, Liu Y, Wang Z, Cao B Sci China Life Sci. 2024; 67(11):2323-2343.

PMID: 39083202 DOI: 10.1007/s11427-024-2643-1.

Examining the immunological responses to COVID-19 vaccination in multiple myeloma patients: a systematic review and meta-analysis.

Harandi H, Fallahtafti P, Karimi A, Hashemi S, Mahalleh M, Ashouri M BMC Geriatr. 2024; 24(1):411.

PMID: 38720296 PMC: 11080142. DOI: 10.1186/s12877-024-05006-0.

References

Sandherr M, Hentrich M, von Lilienfeld-Toal M, Massenkeil G, Neumann S, Penack O . Antiviral prophylaxis in patients with solid tumours and haematological malignancies--update of the Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO). Ann Hematol. 2015; 94(9):1441-50. PMC: 4525190. DOI: 10.1007/s00277-015-2447-3. View

Cunningham A, Lal H, Kovac M, Chlibek R, Hwang S, Diez-Domingo J . Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older. N Engl J Med. 2016; 375(11):1019-32. DOI: 10.1056/NEJMoa1603800. View

van der Does-van den Berg A, Hermans J, Nagel J, van Steenis G . Immunity to diphtheria, pertussis, tetanus, and poliomyelitis in children with acute lymphocytic leukemia after cessation of chemotherapy. Pediatrics. 1981; 67(2):222-9. View

Briere E, Rubin L, Moro P, Cohn A, Clark T, Messonnier N . Prevention and control of haemophilus influenzae type b disease: recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep. 2014; 63(RR-01):1-14. View

Chan C, Molrine D, Antin J, Wheeler C, Guinan E, Weinstein H . Antibody responses to tetanus toxoid and Haemophilus influenzae type b conjugate vaccines following autologous peripheral blood stem cell transplantation (PBSCT). Bone Marrow Transplant. 1997; 20(1):33-8. DOI: 10.1038/sj.bmt.1700843. View

Shahgholi E, Ehsani M, Salamati P, Maysamie A, Sotoudeh K, Mokhtariazad T . Immunogenicity of trivalent influenza vaccine in children with acute lymphoblastic leukemia during maintenance therapy. Pediatr Blood Cancer. 2010; 54(5):716-20. DOI: 10.1002/pbc.22421. View

Redman R, Nader S, Zerboni L, Liu C, Wong R, BROWN B . Early reconstitution of immunity and decreased severity of herpes zoster in bone marrow transplant recipients immunized with inactivated varicella vaccine. J Infect Dis. 1997; 176(3):578-85. DOI: 10.1086/514077. View

Engelhard D, Mohty B, de la Camara R, Cordonnier C, Ljungman P . European guidelines for prevention and management of influenza in hematopoietic stem cell transplantation and leukemia patients: summary of ECIL-4 (2011), on behalf of ECIL, a joint venture of EBMT, EORTC, ICHS, and ELN. Transpl Infect Dis. 2013; 15(3):219-32. DOI: 10.1111/tid.12054. View

Onozawa M, Hashino S, Darmanin S, Okada K, Morita R, Takahata M . HB vaccination in the prevention of viral reactivation in allogeneic hematopoietic stem cell transplantation recipients with previous HBV infection. Biol Blood Marrow Transplant. 2008; 14(11):1226-30. DOI: 10.1016/j.bbmt.2008.08.007. View

10.

Shatz D . Vaccination considerations in the asplenic patient. Expert Rev Vaccines. 2005; 4(1):27-34. DOI: 10.1586/14760584.4.1.27. View

11.

Markowitz L, Dunne E, Saraiya M, Lawson H, Chesson H, Unger E . Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007; 56(RR-2):1-24. View

12.

Garcia Garrido H, Wieten R, Grobusch M, Goorhuis A . Response to Hepatitis A Vaccination in Immunocompromised Travelers. J Infect Dis. 2015; 212(3):378-85. DOI: 10.1093/infdis/jiv060. View

13.

Rousseau B, Loulergue P, Mir O, Krivine A, Kotti S, Viel E . Immunogenicity and safety of the influenza A H1N1v 2009 vaccine in cancer patients treated with cytotoxic chemotherapy and/or targeted therapy: the VACANCE study. Ann Oncol. 2011; 23(2):450-7. DOI: 10.1093/annonc/mdr141. View

14.

Sinisalo M, Aittoniemi J, Oivanen P, Kayhty H, Olander R, Vilpo J . Response to vaccination against different types of antigens in patients with chronic lymphocytic leukaemia. Br J Haematol. 2001; 114(1):107-10. DOI: 10.1046/j.1365-2141.2001.02882.x. View

15.

Azevedo L, Lasmar E, Contieri F, Boin I, Percegona L, Saber L . Yellow fever vaccination in organ transplanted patients: is it safe? A multicenter study. Transpl Infect Dis. 2011; 14(3):237-41. DOI: 10.1111/j.1399-3062.2011.00686.x. View

16.

Koksal Y, Yalcin B, Aydin G, Sari N, Yazici N, Varan A . Immunogenicity of hepatitis a vaccine in children with cancer. Pediatr Hematol Oncol. 2006; 23(8):619-24. DOI: 10.1080/08880010600907239. View

17.

Kristensen K . Antibody response to a Haemophilus influenzae type b polysaccharide tetanus toxoid conjugate vaccine in splenectomized children and adolescents. Scand J Infect Dis. 1992; 24(5):629-32. DOI: 10.3109/00365549209054649. View

18.

Urun Y, Akbulut H, Demirkazik A, Cay Senler F, Utkan G, Onur H . Perception about influenza and pneumococcal vaccines and vaccination coverage among patients with malignancies and their family members. J BUON. 2013; 18(2):511-5. View

19.

Cheuk D, Chiang A, Lee T, Chan G, Ha S . Vaccines for prophylaxis of viral infections in patients with hematological malignancies. Cochrane Database Syst Rev. 2011; (3):CD006505. DOI: 10.1002/14651858.CD006505.pub2. View

20.

Ullmann A, Akova M, Herbrecht R, Viscoli C, Arendrup M, Arikan-Akdagli S . ESCMID* guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT). Clin Microbiol Infect. 2012; 18 Suppl 7:53-67. DOI: 10.1111/1469-0691.12041. View